What are the Challenges of Using Nanotechnology in Treating Metastatic Cancer?
Despite its advantages, there are several challenges to using nanotechnology in metastatic cancer treatment:
Biocompatibility: Ensuring nanoparticles are non-toxic and do not elicit an immune response. Drug Resistance: Cancer cells may develop resistance to drugs delivered by nanocarriers. Cost: High costs in developing and manufacturing nanomedicines. Regulatory Hurdles: Stringent regulatory requirements for approval. Delivery Efficiency: Ensuring nanoparticles effectively reach and penetrate tumors.
